Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 40 articles:
HTML format
Text format



Single Articles


    July 2018
  1. REDMAN JS, Sterling RK
    Treating HCV in a Captive Audience: Eradication Efforts in the Prison Microenvironment.
    Am J Gastroenterol. 2018 Jul 24. pii: 10.1038/s41395-018-0201.
    PubMed     Text format     Abstract available


  2. YOUNOSSI ZM
    Disparities in Access to Direct Acting Antiviral Regimens for Hepatitis C Virus (HCV): The Impact of Race and Insurance Status.
    Am J Gastroenterol. 2018 Jul 18. pii: 10.1038/s41395-018-0200.
    PubMed     Text format     Abstract available


    June 2018
  3. HUSSEN N, Zhu L, Tetangco E, Ellison S, et al
    Hepatoptosis in a Patient with Alcoholic Hepatitis.
    Am J Gastroenterol. 2018 Jun 29. pii: 10.1038/s41395-018-0182.
    PubMed     Text format    


  4. CUADRADO A, Llerena S, Cobo C, Pallas JR, et al
    Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0157.
    PubMed     Text format     Abstract available


  5. KRAWCZYK M, Gaweda B, Kosnik A, Rejowski S, et al
    Successful DAA-Based Treatment of Hcv-Related Fibrosing Cholestatic Hepatitis After Liver Transplantation Due to a Fulminant Liver Failure.
    Am J Gastroenterol. 2018 Jun 21. pii: 10.1038/s41395-018-0078.
    PubMed     Text format    


  6. PHILIPS CA, Paramaguru R, Augustine P
    Severe Alcoholic Hepatitis in a Teetotaler.
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0154.
    PubMed     Text format    


  7. SHIN JW, Jung SW, Lee SB, Lee BU, et al
    Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir.
    Am J Gastroenterol. 2018 Jun 8. pii: 10.1038/s41395-018-0093.
    PubMed     Text format     Abstract available


    May 2018
  8. SCHMELTZER PA, Russo MW
    Clinical narrative: autoimmune hepatitis.
    Am J Gastroenterol. 2018 May 14. pii: 10.1038/s41395-018-0058.
    PubMed     Text format     Abstract available


    April 2018
  9. ZAMOR PJ, Vierling J, Ghalib R, Luketic V, et al
    Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trials.
    Am J Gastroenterol. 2018 Apr 26. pii: 10.1038/s41395-018-0053.
    PubMed     Text format     Abstract available


  10. PERRELLA A, Rinaldi L, Galeota-Lanza A, Izzi A, et al
    DAAs and long-term clinical outcome in hepatitis C: the panacea for all diseases still does not exist.
    Am J Gastroenterol. 2018 Apr 24. pii: 10.1038/s41395-018-0062.
    PubMed     Text format    


    March 2018
  11. WONG RJ, Jain MK, Therapondos G, Shiffman ML, et al
    Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment.
    Am J Gastroenterol. 2018 Mar 9. pii: 10.1038/s41395-018-0033.
    PubMed     Text format     Abstract available


    February 2018
  12. YI W, Pan CQ, Li MH, Wan G, et al
    The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B.
    Am J Gastroenterol. 2018 Feb 27. pii: 10.1038/s41395-018-0010.
    PubMed     Text format     Abstract available


    January 2018
  13. WEN JW, Kohn MA, Wong R, Somsouk M, et al
    Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans.
    Am J Gastroenterol. 2018 Jan 30. pii: ajg2017456. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


    December 2017
  14. HUANG YW, Lee CL, Yang SS, Fu SC, et al
    Corrigendum: Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Am J Gastroenterol. 2017 Dec 26. pii: ajg2017494. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  15. BUNCHORNTAVAKUL C, Reddy KR
    HCV Therapy in Decompensated Cirrhosis before or after Liver Transplantation: A Paradoxical Quandary.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017435. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  16. UMASHANKER R
    Continuing Medical Education Questions: December 2017: Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.
    Am J Gastroenterol. 2017;112:1789.
    PubMed     Text format    


  17. NGUYEN MH, Trinh H, Do S, Nguyen T, et al
    Open Label Study of 8 vs. 12 Weeks of Ledipasvir/Sofosbuvir in Genotype 6 Treatment Naive or Experienced Patients.
    Am J Gastroenterol. 2017;112:1824-1831.
    PubMed     Text format     Abstract available


    November 2017
  18. KWO PY, Shiffman ML, Bernstein DE
    The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  19. SOLLIMA S, Milazzo L, Antinori S, Galli M, et al
    Direct-Acting Antivirals and Mixed Cryoglobulinemia Vasculitis: Long-Term Outcome of Patients Achieving HCV Eradication.
    Am J Gastroenterol. 2017;112:1753-1754.
    PubMed     Text format    


  20. LIU X, Shen JJ, Lee JL, Yoo JW, et al
    Cost-Effective but Unaffordable and Unequal Hepatitis C Treatment in the US.
    Am J Gastroenterol. 2017;112:1749.
    PubMed     Text format    


  21. FUKUI N, Golabi P, Otgonsuren M, Mishra A, et al
    Demographics, Resource Utilization, and Outcomes of Elderly Patients With Chronic Liver Disease Receiving Hospice Care in the United States.
    Am J Gastroenterol. 2017;112:1700-1708.
    PubMed     Text format     Abstract available


    October 2017
  22. WU T, Kwok RM, Tran TT
    Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.
    Am J Gastroenterol. 2017 Oct 31. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  23. KECK C, Shetty A, Mischen B, Willner I, et al
    Hepatic Splenosis Masquerading as Hepatocellular Carcinoma in a Chronic Hepatitis C Patient.
    Am J Gastroenterol. 2017;112:1493.
    PubMed     Text format    


    September 2017
  24. CHON YE, Park JY, Myoung SM, Jung KS, et al
    Corrigendum: Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    Am J Gastroenterol. 2017 Sep 12. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  25. HUANG R, Yan X, Liu Y, Zhang Z, et al
    Can Transient Elastography Predict Fibrosis Regression in Patients with Chronic Hepatitis B During Long-Term Antiviral Therapy?
    Am J Gastroenterol. 2017;112:1477-1478.
    PubMed     Text format    


  26. KOFF RS
    Editorial: Direct Antiviral Agents Eliminate the Age Barrier to Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017;112:1410-1411.
    PubMed     Text format     Abstract available


  27. LENS S, Fernandez I, Rodriguez-Tajes S, Hontangas V, et al
    Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2017;112:1400-1409.
    PubMed     Text format     Abstract available


    August 2017
  28. TSENG TC, Liu CJ, Su TH, Yang WT, et al
    Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2017 Aug 29. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  29. MARTIN P, Fabrizi F
    Editorial: Benefit of Direct-Acting Antiviral Therapy For Cryoglobulinemia due to Hepatitis C Infection.
    Am J Gastroenterol. 2017;112:1309-1310.
    PubMed     Text format     Abstract available


  30. EMERY JS, Kuczynski M, La D, Almarzooqi S, et al
    Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.
    Am J Gastroenterol. 2017;112:1298-1308.
    PubMed     Text format     Abstract available


    July 2017
  31. PELLICANO R
    Is Viral Hepatitis Decreasing in the United States?
    Am J Gastroenterol. 2017;112:1170.
    PubMed     Text format    


    June 2017
  32. TOYODA H, Kumada T, Tada T
    Hepatitis B Core-Related Antigen: A Possible Indicator for the Termination of Prophylactic Nucleos(t)ide Analogue Therapy in Patients After Immunosuppressive Therapy.
    Am J Gastroenterol. 2017;112:969-970.
    PubMed     Text format    


    April 2017
  33. LEE MH, Hsiao TI, Subramaniam SR, Le AK, et al
    HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2017 Apr 25. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  34. OOKA K, Connolly JJ, Lim JK
    Medicaid Reimbursement for Oral Direct Antiviral Agents for the Treatment of Chronic Hepatitis C.
    Am J Gastroenterol. 2017 Apr 4. doi: 10.1038/ajg.2017.
    PubMed     Text format    


  35. CHON YE, Park JY, Myoung SM, Jung KS, et al
    Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
    Am J Gastroenterol. 2017 Apr 4. doi: 10.1038/ajg.2017.
    PubMed     Text format     Abstract available


  36. GARCIA-SAENZ-DE-SICILIA M, Duvoor C, Altamirano J, Chavez-Araujo R, et al
    Corrigendum: A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.
    Am J Gastroenterol. 2017;112:666.
    PubMed     Text format    


    January 2017
  37. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Text format     Abstract available


  38. KWO PY, Cohen SM, Lim JK
    ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
    Am J Gastroenterol. 2017;112:18-35.
    PubMed     Text format     Abstract available


    August 2016
  39. TROJAN J, Sarrazin C
    Complete Response of Hepatocellular Carcinoma in a Patient With End-stage Liver Disease treated With Nivolumab: Whishful thinking or Possible?
    Am J Gastroenterol. 2016;111:1208-9.
    PubMed     Text format    


    July 2016
  40. DI COSTANZO GG, Marino Marsilia G, Tortora R, Di Costanzo G, et al
    Hepatocellular Carcinoma With Peliosis-Like Change-Mimicking Hemangioma: A LI-RADS Exception.
    Am J Gastroenterol. 2016;111:1038-40.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: